ROYAL BANK OF CANADA - KRYSTAL BIOTECH INC ownership

KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 111 filers reported holding KRYSTAL BIOTECH INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of KRYSTAL BIOTECH INC
ValueSharesWeighting
Q3 2023$841,000
+359.6%
7,249
+361.1%
0.00%
Q2 2023$183,000
+76.0%
1,572
+21.3%
0.00%
Q1 2023$104,000
-57.2%
1,296
-57.6%
0.00%
Q4 2022$243,000
+737.9%
3,058
+631.6%
0.00%
Q3 2022$29,000
+52.6%
418
+44.6%
0.00%
Q2 2022$19,000
-81.4%
289
-81.1%
0.00%
Q1 2022$102,000
-59.0%
1,532
-57.1%
0.00%
Q4 2021$249,000
+1085.7%
3,568
+798.7%
0.00%
Q3 2021$21,000
+250.0%
397
+341.1%
0.00%
Q2 2021$6,000
-92.9%
90
-91.8%
0.00%
Q1 2021$85,000
+372.2%
1,098
+269.7%
0.00%
Q4 2020$18,000
+350.0%
297
+301.4%
0.00%
Q3 2020$4,000
+33.3%
74
-14.0%
0.00%
Q2 2020$3,000
+50.0%
86
+59.3%
0.00%
Q1 2020$2,00054
+390.9%
0.00%
Q3 2018$0110.00%
Other shareholders
KRYSTAL BIOTECH INC shareholders Q4 2020
NameSharesValueWeighting ↓
FRAZIER MANAGEMENT LLC 771,250$53,949,0004.15%
First Light Asset Management, LLC 680,170$47,578,0003.41%
ACT CAPITAL MANAGEMENT, LLC 59,000$4,127,0002.98%
S Squared Technology, LLC 95,215$6,660,0002.98%
Redmile Group, LLC 1,820,898$127,372,0002.90%
Soleus Capital Management, L.P. 228,437$15,979,0001.60%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 50,922$3,562,0001.59%
Artal Group S.A. 700,000$48,965,0001.33%
SILVERARC CAPITAL MANAGEMENT, LLC 46,670$3,265,0001.32%
Kynam Capital Management, LP 34,816$2,435,0001.30%
View complete list of KRYSTAL BIOTECH INC shareholders